The interdisciplinary Nanovaccine Institute, which the Iowa Board of Regents approved in June 2017 but has functioned as a multi-institution research venture since 2013, will get a home on the unfinished fifth floor of the new Advanced Teaching and Research Building. The regents gave their approval for planning to begin for a headquarters and state-of-the-art research space. Anson Marston Distinguished Professor in chemical and biological engineering Balaji Narasimhan serves as director for the institute, which includes about 70 scientists from 21 universities, health care companies, and national laboratories. Their aim is to revolutionize how diseases are prevented and treated through nano-scale vaccines and therapeutics. The project budget is estimated at up to $6.5 million, to be covered by university funds and private gifts. The building’s lower floors are scheduled to open next semester.
— Ann Krapfl, ISU University Relations, 12/7/17